HUMBLEYARD PRACTICE — All Prescriptions & Medications — Page 13
Practice Code: D82064 | NORWICH, NR4 6TA
Showing results 601-650 of 711
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Frovatriptan | 18 | 126 | £286 | +27.3% ▲ |
| Galantamine | 18 | 3,084 | £2.6K | -52.4% ▼ |
| Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | 18 | 630 | £329 | -29.9% ▼ |
| Tube feed 1.5 kcal/ml peptide based (0914041) | 18 | 570.0K | £12.2K | +69.1% ▲ |
| 18 | 277 | £1.1K | +180.2% ▲ | |
| 18 | 28 | £129 | -55.8% ▼ | |
| 18 | 115 | £253 | +176.8% ▲ | |
| 18 | 4,300 | £426 | -62.7% ▼ | |
| 18 | 1,900 | £263 | +36.4% ▲ | |
| 18 | 240 | £833 | +18.3% ▲ | |
| Magnesium aspartate | 17 | 843 | £563 | +12.3% ▲ |
| RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | 17 | 125.8K | £1.4K | -9.2% ▼ |
| Tube feed 1.5 kcal/ml with fibre, higher protein (0914011) | 17 | 252.0K | £4.0K | +180.1% ▲ |
| Indometacin | 17 | 868 | £55 | +8.0% ▲ |
| Gentamicin sulfate | 17 | 170 | £321 | +209.4% ▲ |
| Acetic acid | 17 | 85 | £78 | +46.8% ▲ |
| 17 | 1,470 | £3.1K | +104.1% ▲ | |
| 17 | 1,680 | £5.9K | -54.8% ▼ | |
| 17 | 1,188 | £254 | -42.1% ▼ | |
| Naftidrofuryl oxalate | 16 | 2,436 | £259 | -50.9% ▼ |
| Oxazepam | 16 | 448 | £53 | -24.9% ▼ |
| Clindamycin hydrochloride | 16 | 766 | £200 | +59.8% ▲ |
| Ciprofloxain/dexameth | 16 | 80 | £93 | -47.9% ▼ |
| Azelastine hydrochloride | 16 | 350 | £157 | +42.7% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 16 | 16 | £225 | -85.9% ▼ |
| Eflornithine monohydrate chloride | 16 | 960 | £865 | +127.7% ▲ |
| 16 | 1,100 | £6.0K | +153.5% ▲ | |
| Sodium citrate (Rectal) | 15 | 414 | £271 | +8.7% ▲ |
| Minoxidil | 15 | 468 | £89 | +34.6% ▲ |
| Zuclopenthixol hydrochloride | 15 | 2,400 | £86 | -52.4% ▼ |
| Nicotine | 15 | 1,627 | £1.7K | -73.4% ▼ |
| Biphasic insulin lispro | 15 | 300 | £1.8K | -65.1% ▼ |
| Fusidic acid | 15 | 75 | £261 | +45.2% ▲ |
| 15 | 490 | £2.3K | -29.0% ▼ | |
| 15 | 140 | £1.2K | -46.1% ▼ | |
| 15 | 1,182 | £109 | -25.8% ▼ | |
| 15 | 30 | £1.9K | +65.3% ▲ | |
| 15 | 54 | £1.7K | +108.3% ▲ | |
| Cimetidine | 14 | 840 | £77 | -24.9% ▼ |
| Telmisartan with diuretic | 14 | 392 | £109 | +23.8% ▲ |
| Inclisiran | 14 | 14 | £640 | +11.1% ▲ |
| Cenobamate | 14 | 448 | £2.2K | -42.2% ▼ |
| Ryeqo | 14 | 392 | £958 | +148.7% ▲ |
| Cocois | 14 | 1,560 | £237 | +2.0% ▲ |
| Other individually formulated bought in preparations | 14 | 623 | £389 | -57.1% ▼ |
| 14 | 400 | £1.4K | +111.2% ▲ | |
| Methyldopa | 13 | 1,400 | £300 | -23.7% ▼ |
| Formoterol/glycopyrronium/budesonide | 13 | 14 | £592 | -78.4% ▼ |
| Lormetazepam | 13 | 800 | £266 | +10.4% ▲ |
| Phenobarbital | 13 | 364 | £11 | -57.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.